NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,113 | -98.9% | 492,500 | +1486.2% | 0.02% | +1500.0% |
Q3 2022 | $99,000 | -95.6% | 31,049 | -92.5% | 0.00% | -96.4% |
Q1 2022 | $2,241,000 | +694.7% | 415,709 | +1890.6% | 0.03% | +833.3% |
Q4 2021 | $282,000 | -72.3% | 20,884 | -63.2% | 0.00% | -78.6% |
Q3 2021 | $1,019,000 | +38.3% | 56,756 | +32.1% | 0.01% | +75.0% |
Q2 2021 | $737,000 | +162.3% | 42,964 | +159.7% | 0.01% | +166.7% |
Q4 2020 | $281,000 | -66.5% | 16,544 | -67.2% | 0.00% | -82.4% |
Q3 2020 | $838,000 | +1.7% | 50,503 | +42.0% | 0.02% | -19.0% |
Q2 2020 | $824,000 | -7.5% | 35,558 | -13.9% | 0.02% | +23.5% |
Q4 2019 | $891,000 | – | 41,279 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
TOBAM | 640,547 | $21,522,000 | 1.09% |
Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |